MP27-13 THE IMPACT ON THE TYPE OF URETERAL STENT TO PATIENTS¡¯ SYMPTOM USING USSQ: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY

Abstract

You have accessJournal of UrologyStone Disease: Therapy III1 Apr 2014MP27-13 THE IMPACT ON THE TYPE OF URETERAL STENT TO PATIENTS¡¯ SYMPTOM USING USSQ: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY Hyoungkeun Park, Sangrak Bae, Sunghyun Paick, Hyunwoo Kim, Jutae Seo, Joonchul Kim, Wonhee Park, Yongsoo Lho, and Hyeonggon Kim Hyoungkeun ParkHyoungkeun Park More articles by this author , Sangrak BaeSangrak Bae More articles by this author , Sunghyun PaickSunghyun Paick More articles by this author , Hyunwoo KimHyunwoo Kim More articles by this author , Jutae SeoJutae Seo More articles by this author , Joonchul KimJoonchul Kim More articles by this author , Wonhee ParkWonhee Park More articles by this author , Yongsoo LhoYongsoo Lho More articles by this author , and Hyeonggon KimHyeonggon Kim More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2014.02.376AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES To minimize stent related symptom, new type of ureteral stent, PolarisTM was developed and recently released in the market. PolarisTM is composed of firm material in proximal part and soft material in distal part which would be expected to make patients feel less irritation and pain. The aim of this study was to compare stent-related symptom between PolarisTM and conventional ureteral stent (Percuflex¢ç) with Ureteral Stent Symptom Questionnaire (USSQ) and visual analogue pain scale (VAS). METHODS A total 104 patients were randomized to PolarisTM (n=50) or Percuflex¢ç (n=54) group when ureteral stent was inserted after ureteroscopic stone removal surgery. The type of stent was chosen by using randomization program at that time of stent insertion. After 1 week of surgery, patient¡¯s symptoms in each group were evaluated by Ureteral Stent Symptom Questionnaire (USSQ) which contained 6 domains of voiding symptom, pain, general health, work, sexual activity, and others. Patients were also asked to fill unmarked 10cm VAS. Mean score of each domain and mean VAS were compared between two groups. RESULTS Mean age of patients was 51.1 years and male-to-female ratio was 1:0.85. There were no significant differences in the domain scores of urinary symptoms between PolarisTM and Percuflex¢ç (29.7¡¾10.5 vs. 30.2¡¾8.6, p=0.617), pain (18.1¡¾11.8 vs 19.9¡¾11.1, p=0.970), general health (13.9¡¾5.9 vs. 15.4¡¾7.2, p=0.059), work (12.6¡¾12.6 vs 16.4¡¾12.7, p=0.140), sexual activity (2.3¡¾2.6 vs. 2.4¡¾2.9, p=0.987), and additional problems (9.2¡¾5.0 vs 10.2¡¾4.8, p=0.584). In VAS, there was also no significant difference between PolarisTM and Percuflex¢ç groups (5.3¡¾2.5 vs. 5.3¡¾3.1, p=0.98). CONCLUSIONS Compared to conventional ureteral stent, Polaris, new ureteral stent with soft tail, showed no significant differences in voiding symptom, body pain, general health, sexual matters, and additional problems. VAS confirmed no difference in pain aspect between two group. The ureteral stent which had soft material tip did not have any clinical advantages compared to conventional ureteral stent. © 2014FiguresReferencesRelatedDetails Volume 191Issue 4SApril 2014Page: e279 Advertisement Copyright & Permissions© 2014MetricsAuthor Information Hyoungkeun Park More articles by this author Sangrak Bae More articles by this author Sunghyun Paick More articles by this author Hyunwoo Kim More articles by this author Jutae Seo More articles by this author Joonchul Kim More articles by this author Wonhee Park More articles by this author Yongsoo Lho More articles by this author Hyeonggon Kim More articles by this author Expand All Advertisement Advertisement PDF DownloadLoading ...